STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
| Description | |
| Date de publication | |
| Auteurs | Delyon J, Chevret S, Jouary T, Dalac S, Dalle S, Guillot B, Arnault JP, Avril MF, Bedane C, Bens G, Pham-Ledard A, Mansard S, Grange F, Machet L, Meyer N, Legoupil D, Saiag P, Idir Z, Renault V, Deleuze JF, Hindie E, Battistella M, Dumaz N, Mourah S, Lebbe C and Canc GCCFGS |
| Revue | |
| Année | 2 018 |
| Institut | |
| Département / Service | |
| Laboratoire | |
| Date de création | |
| Facteur Impact | |
| url DOI | 10.1016/j.jid.2017.07.839 |